Virginie Eclache

Summary

Country: France

Publications

  1. ncbi request reprint A new variant t(6;15;17)(q25;q22;q21) in acute promyelocytic leukemia: fluorescence in situ hybridization confirmation
    Virginie Eclache
    Laboratoire d Hematologie, Hopital Jean Verdier, Bondy, France
    Cancer Genet Cytogenet 159:69-73. 2005
  2. ncbi request reprint Clinical and biological features associated with taste loss in internal medicine patients. A cross-sectional study of 100 cases
    Adrien Kettaneh
    Department of Internal Medicine, Hopital Saint Antoine, 75012 Paris, France
    Appetite 44:163-9. 2005
  3. ncbi request reprint Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients
    Philippe Casassus
    Service d Hematologie Clinique, Hopital Avicenne, Universite Paris Nord, Bobigny, Paris, France
    Br J Haematol 119:1090-7. 2002
  4. ncbi request reprint Pica and food craving in patients with iron-deficiency anemia: a case-control study in France
    Adrien Kettaneh
    Department of Internal Medicine, Hopital Jean Verdier, Bondy, France
    Am J Med 118:185-8. 2005
  5. ncbi request reprint A constitutional translocation t(1;4)(p21;p15) in a case of chronic lymphocytic leukemia
    Virginie Eclache
    Laboratoire d Hematologie, Hopital Jean Verdier, Avenue du 14 Juillet, 93145 cedex, Bondy, France virginie
    Ann Genet 45:169-71. 2002
  6. ncbi request reprint Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders
    Virginie Eclache
    Laboratoire d Hematologie, Unité Fonctionelle d Hématologie, Hopital Jean Verdier, Avenue du 14 Juillet, 93145 Bondy Cedex, France
    Cancer Genet Cytogenet 152:72-6. 2004
  7. doi request reprint Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia
    Claude Preudhomme
    Laboratoire d Hematologie, Centre Hospitalier Universitaire de Lille, and INSERM Unité 837, Lille, France
    N Engl J Med 363:2511-21. 2010
  8. ncbi request reprint M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH)
    Christophe Roumier
    Laboratoire d Hematologie A, Laboratoire de Cytogenetique, and Service des Maladies du Sang, CHU Lille, France
    Blood 101:1277-83. 2003
  9. ncbi request reprint Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder
    Anne Etienne
    Centre de Recherche en Cancerologie de Marseille, Départements d Oncologie Moléculaire et d Hématologie Moléculaire, UMR599 Inserm, Institut Paoli Calmettes, 27 Bd Lei Roure, 13009, Marseille, France
    Cancer Genet Cytogenet 173:154-8. 2007
  10. doi request reprint Mechanisms of genesis of variant translocation in chronic myeloid leukemia are not correlated with ABL1 or BCR deletion status or response to imatinib therapy
    Steven Richebourg
    Laboratory of Medical Genetics, Hospital Jeanne de Flandre, University Hospital Regional Center CHRU, avenue Eugene Avinee, 59037 Lille Cedex, France
    Cancer Genet Cytogenet 182:95-102. 2008

Collaborators

Detail Information

Publications13

  1. ncbi request reprint A new variant t(6;15;17)(q25;q22;q21) in acute promyelocytic leukemia: fluorescence in situ hybridization confirmation
    Virginie Eclache
    Laboratoire d Hematologie, Hopital Jean Verdier, Bondy, France
    Cancer Genet Cytogenet 159:69-73. 2005
    ..This case illustrates the usefulness of combined cytogenetics, FISH, and molecular biology to evidence the PML/RARalpha fusion gene in complex cases...
  2. ncbi request reprint Clinical and biological features associated with taste loss in internal medicine patients. A cross-sectional study of 100 cases
    Adrien Kettaneh
    Department of Internal Medicine, Hopital Saint Antoine, 75012 Paris, France
    Appetite 44:163-9. 2005
    ..Inpatients may be screened for taste loss by a few features, to identify those for whom a nutritional intervention should be focused...
  3. ncbi request reprint Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients
    Philippe Casassus
    Service d Hematologie Clinique, Hopital Avicenne, Universite Paris Nord, Bobigny, Paris, France
    Br J Haematol 119:1090-7. 2002
    ..Two patients died soon after starting therapy (one myocardial infarction, one septic shock). Six months of interferon-alpha may relieve vascular congestion in adults with SM, probably by inhibiting mast-cell degranulation...
  4. ncbi request reprint Pica and food craving in patients with iron-deficiency anemia: a case-control study in France
    Adrien Kettaneh
    Department of Internal Medicine, Hopital Jean Verdier, Bondy, France
    Am J Med 118:185-8. 2005
  5. ncbi request reprint A constitutional translocation t(1;4)(p21;p15) in a case of chronic lymphocytic leukemia
    Virginie Eclache
    Laboratoire d Hematologie, Hopital Jean Verdier, Avenue du 14 Juillet, 93145 cedex, Bondy, France virginie
    Ann Genet 45:169-71. 2002
  6. ncbi request reprint Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders
    Virginie Eclache
    Laboratoire d Hematologie, Unité Fonctionelle d Hématologie, Hopital Jean Verdier, Avenue du 14 Juillet, 93145 Bondy Cedex, France
    Cancer Genet Cytogenet 152:72-6. 2004
    ..These data show that our FISH set of probes efficiently detects ATM deletions in CLL. No correlation was found between ATM deletions and CD38 expression level. These results confirm the prognostic significance of ATM deletions in CLL...
  7. doi request reprint Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia
    Claude Preudhomme
    Laboratoire d Hematologie, Centre Hospitalier Universitaire de Lille, and INSERM Unité 837, Lille, France
    N Engl J Med 363:2511-21. 2010
    ..However, only a minority of patients treated with imatinib have a complete molecular remission...
  8. ncbi request reprint M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH)
    Christophe Roumier
    Laboratoire d Hematologie A, Laboratoire de Cytogenetique, and Service des Maladies du Sang, CHU Lille, France
    Blood 101:1277-83. 2003
    ..0001), and with a borderline significant lower incidence of complex karyotypes. In the 59 patients, FLT3 mutations were the only significant prognostic factors associated with short survival...
  9. ncbi request reprint Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder
    Anne Etienne
    Centre de Recherche en Cancerologie de Marseille, Départements d Oncologie Moléculaire et d Hématologie Moléculaire, UMR599 Inserm, Institut Paoli Calmettes, 27 Bd Lei Roure, 13009, Marseille, France
    Cancer Genet Cytogenet 173:154-8. 2007
    ..Potential tumor suppressor genes affected by the deletion by loss (IFT88, CRYL1, TACC1) or break (LATS2) may participate in the malignant process...
  10. doi request reprint Mechanisms of genesis of variant translocation in chronic myeloid leukemia are not correlated with ABL1 or BCR deletion status or response to imatinib therapy
    Steven Richebourg
    Laboratory of Medical Genetics, Hospital Jeanne de Flandre, University Hospital Regional Center CHRU, avenue Eugene Avinee, 59037 Lille Cedex, France
    Cancer Genet Cytogenet 182:95-102. 2008
    ..5%) harbored ABL1 or BCR deletions that are not significantly associated with the complexity of translocation genesis. We also found no association between one-step, two-step, or multistep mechanisms and the response to imatinib therapy...
  11. doi request reprint The role of lenalidomide in the management of myelodysplasia with del 5q
    Charikleia Kelaidi
    Hôpital Avicenne Assistance Publique, Hopitaux de Paris, University Paris 13, Bobigny, France
    Br J Haematol 140:267-78. 2008
    ..Therefore, lenalidomide may have an effect on disease course and survival, which is currently being assessed in clinical trials...
  12. doi request reprint Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes
    Jean Jacques Kiladjian
    INSERM U753, Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif, 94805, France
    Haematologica 93:381-9. 2008
    ..T-cell receptor gammadelta T cells are other important components of innate immunity that have been recently implicated in the immune response against hematologic malignancies...
  13. ncbi request reprint CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique
    Dominique Leroux
    Laboratoire d hématologie cellulaire et moléculaire, Centre Hospitalier Universitaire CHU Michallon, Grenoble, France
    Blood 99:4154-9. 2002
    ..In conclusion, the present study documents for the first time the existence of a characteristic cytogenetic profile for this novel disease entity...